Eli Lilly and Johnson & Johnson, PPH’s largest holdings, are facing unique challenges, impacting the ETF’s overall performance. See why PPH ETF is a Hold.
PPH: Global Pharma Stocks Continue To Face Headwinds, Tariffs Front And Center
view original post